Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
42.00
+0.42 (1.01%)
At close: Jan 2, 2025, 4:00 PM
42.40
+0.40 (0.95%)
After-hours: Jan 2, 2025, 7:59 PM EST
Moderna Market Cap
Moderna has a market cap or net worth of $16.16 billion as of January 2, 2025. Its market cap has decreased by -50.38% in one year.
Market Cap
16.16B
Enterprise Value
8.32B
1-Year Change
-50.38%
Ranking
Category
Stock Price
$42.00
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $16.16B, an increase of 164.16%. That is a compound annual growth rate of 17.33%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.13B |
| UnitedHealth Group | 465.54B |
| Novo Nordisk | 384.34B |
| Johnson & Johnson | 348.19B |
| AbbVie | 314.02B |
| Merck & Co. | 251.65B |
| AstraZeneca | 203.17B |
| Thermo Fisher Scientific | 198.99B |